Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure
- 1 August 1984
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 4 (2), 364-371
- https://doi.org/10.1016/s0735-1097(84)80227-2
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Combined vasodilator and inotropic therapy of heart failure: Experimental and clinical conceptsAmerican Heart Journal, 1981
- Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure.Circulation, 1978
- The rate-pressure product as an index of myocardial oxygen consumption during exercise in patients with angina pectoris.Circulation, 1978
- Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.Circulation, 1977
- The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.Circulation, 1977
- Heart rate and arterial blood pressure during exercise in patients with angina pectoris. Effects of training and of nitroglycerin.Circulation, 1976
- Influence of acute changes in preload, afterload, contractile state and heart rate on ejection and isovolumic indices of myocardial contractility in man.Circulation, 1976
- Hemodynamic Predictors of Myocardial Oxygen Consumption During Static and Dynamic ExerciseCirculation, 1974
- Indirect assessment of myocardial oxygen consumption in the evaluation of mechanisms and therapy of angina pectorisThe American Journal of Cardiology, 1974
- A simplified plethysmographic system for the measurement of systemic arterial pressure and peripheral blood flowAmerican Heart Journal, 1962